HuGE Literature Finder
Records
1
-
30
| Fanconi anemia gene-associated germline predisposition in aplastic anemia and hematologic malignancies. Frontiers of medicine 2021 Nov . Nie Daijing, Zhang Jing, Wang Fang, Li Xvxin, Liu Lili, Zhang Wei, Cao Panxiang, Chen Xue, Zhang Yang, Chen Jiaqi, Ma Xiaoli, Zhou Xiaosu, Wu Qisheng, Liu Ming, Liu Mingyue, Tian Wenjun, Liu Hongxi |
| Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer. Frontiers in oncology 2021 11 637431. Zeng Bing, Huang Peide, Du Peina, Sun Xiaohui, Huang Xuanlin, Fang Xiaodong, Li L |
| Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis. Breast cancer research and treatment 2020 Jun . Alter Blanche P, Best Ana |
| FANCL gene mutations in premature ovarian insufficiency. Human mutation 2020 Feb . Yang Yajuan, Guo Ting, Liu Ran, Ke Hanni, Xu Weiwei, Zhao Shidou, Qin Yingyi |
| Two truncating variants in FANCC and breast cancer risk. Scientific reports 2019 Aug 9 (1): 12524. Dörk Thilo, Peterlongo Paolo, Mannermaa Arto, Bolla Manjeet K, Wang Qin, Dennis Joe, Ahearn Thomas, Andrulis Irene L, Anton-Culver Hoda, Arndt Volker, Aronson Kristan J, Augustinsson Annelie, Freeman Laura E Beane, Beckmann Matthias W, Beeghly-Fadiel Alicia, Behrens Sabine, Bermisheva Marina, Blomqvist Carl, Bogdanova Natalia V, Bojesen Stig E, Brauch Hiltrud, Brenner Hermann, Burwinkel Barbara, Canzian Federico, Chan Tsun L, Chang-Claude Jenny, Chanock Stephen J, Choi Ji-Yeob, Christiansen Hans, Clarke Christine L, Couch Fergus J, Czene Kamila, Daly Mary B, Dos-Santos-Silva Isabel, Dwek Miriam, Eccles Diana M, Ekici Arif B, Eriksson Mikael, Evans D Gareth, Fasching Peter A, Figueroa Jonine, Flyger Henrik, Fritschi Lin, Gabrielson Marike, Gago-Dominguez Manuela, Gao Chi, Gapstur Susan M, García-Closas Montserrat, García-Sáenz José A, Gaudet Mia M, Giles Graham G, Goldberg Mark S, Goldgar David E, Guénel Pascal, Haeberle Lothar, Haiman Christopher A, Håkansson Niclas, Hall Per, Hamann Ute, Hartman Mikael, Hauke Jan, Hein Alexander, Hillemanns Peter, Hogervorst Frans B L, Hooning Maartje J, Hopper John L, Howell Tony, Huo Dezheng, Ito Hidemi, Iwasaki Motoki, Jakubowska Anna, Janni Wolfgang, John Esther M, Jung Audrey, Kaaks Rudolf, Kang Daehee, Kapoor Pooja Middha, Khusnutdinova Elza, Kim Sung-Won, Kitahara Cari M, Koutros Stella, Kraft Peter, Kristensen Vessela N, Kwong Ava, Lambrechts Diether, Marchand Loic Le, Li Jingmei, Lindström Sara, Linet Martha, Lo Wing-Yee, Long Jirong, Lophatananon Artitaya, Lubinski Jan, Manoochehri Mehdi, Manoukian Siranoush, Margolin Sara, Martinez Elena, Matsuo Keitaro, Mavroudis Dimitris, Meindl Alfons, Menon Usha, Milne Roger L, Mohd Taib Nur Aishah, Muir Kenneth, Mulligan Anna Marie, Neuhausen Susan L, Nevanlinna Heli, Neven Patrick, Newman William G, Offit Kenneth, Olopade Olufunmilayo I, Olshan Andrew F, Olson Janet E, Olsson Håkan, Park Sue K, Park-Simon Tjoung-Won, Peto Julian, Plaseska-Karanfilska Dijana, Pohl-Rescigno Esther, Presneau Nadege, Rack Brigitte, Radice Paolo, Rashid Muhammad U, Rennert Gad, Rennert Hedy S, Romero Atocha, Ruebner Matthias, Saloustros Emmanouil, Schmidt Marjanka K, Schmutzler Rita K, Schneider Michael O, Schoemaker Minouk J, Scott Christopher, Shen Chen-Yang, Shu Xiao-Ou, Simard Jacques, Slager Susan, Smichkoska Snezhana, Southey Melissa C, Spinelli John J, Stone Jennifer, Surowy Harald, Swerdlow Anthony J, Tamimi Rulla M, Tapper William J, Teo Soo H, Terry Mary Beth, Toland Amanda E, Tollenaar Rob A E M, Torres Diana, Torres-Mejía Gabriela, Troester Melissa A, Truong Thérèse, Tsugane Shoichiro, Untch Michael, Vachon Celine M, Ouweland Ans M W van den, Veen Elke M van, Vijai Joseph, Wendt Camilla, Wolk Alicja, Yu Jyh-Cherng, Zheng Wei, Ziogas Argyrios, Ziv Elad, , , Dunning Alison M, Pharoah Paul D P, Schindler Detlev, Devilee Peter, Easton Douglas |
| Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients? Gynecologic oncology 2019 May . Tomao Federica, Musacchio Lucia, Di Mauro Federica, Boccia Serena Maria, Di Donato Violante, Giancotti Antonella, Perniola Giorgia, Palaia Innocenza, Muzii Ludovico, Benedetti Panici Pierlui |
| BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2017 Nov . Kotsopoulos Joanne, Willows Karla, Trat Sandra, Kim Raymond H, Volenik Alexandra, Sun Ping, Narod Steven A, Boyd Jeffrey, May Taym |
| The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer. European journal of human genetics : EJHG 2016 May . Esteban-Jurado Clara, Franch-Expósito Sebastià, Muñoz Jenifer, Ocaña Teresa, Carballal Sabela, López-Cerón Maria, Cuatrecasas Miriam, Vila-Casadesús Maria, Lozano Juan José, Serra Enric, Beltran Sergi, Brea-Fernández Alejandro, Ruiz-Ponte Clara, Castells Antoni, Bujanda Luis, Garre Pilar, Caldés Trinidad, Cubiella Joaquín, Balaguer Francesc, Castellví-Bel Ser |
| Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patients. Clinical genetics 2016 Jan . Lhota Filip, Zemankova Petra, Kleiblova Petra, Soukupova Jana, Vocka Michal, Stranecky Viktor, Janatova Marketa, Hartmannova Hana, Hodanova Katerina, Kmoch Stanislav, Kleibl Zden |
| DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer. The New England journal of medicine 2015 Oct 373 (18): 1697-708. Mateo Joaquin, Carreira Suzanne, Sandhu Shahneen, Miranda Susana, Mossop Helen, Perez-Lopez Raquel, Nava Rodrigues Daniel, Robinson Dan, Omlin Aurelius, Tunariu Nina, Boysen Gunther, Porta Nuria, Flohr Penny, Gillman Alexa, Figueiredo Ines, Paulding Claire, Seed George, Jain Suneil, Ralph Christy, Protheroe Andrew, Hussain Syed, Jones Robert, Elliott Tony, McGovern Ursula, Bianchini Diletta, Goodall Jane, Zafeiriou Zafeiris, Williamson Chris T, Ferraldeschi Roberta, Riisnaes Ruth, Ebbs Bernardette, Fowler Gemma, Roda Desamparados, Yuan Wei, Wu Yi-Mi, Cao Xuhong, Brough Rachel, Pemberton Helen, A'Hern Roger, Swain Amanda, Kunju Lakshmi P, Eeles Rosalind, Attard Gerhardt, Lord Christopher J, Ashworth Alan, Rubin Mark A, Knudsen Karen E, Feng Felix Y, Chinnaiyan Arul M, Hall Emma, de Bono Johann |
| A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An NRG Oncology/Gynecologic Oncology Group study. Gynecologic oncology 2015 Jun 137 (3): 386-91. Coleman Robert L, Sill Michael W, Bell-McGuinn Katherine, Aghajanian Carol, Gray Heidi J, Tewari Krishnansu S, Rubin Steven C, Rutherford Thomas J, Chan John K, Chen Alice, Swisher Elizabeth |
| Genetic variants in fanconi anemia pathway genes BRCA2 and FANCA predict melanoma survival. The Journal of investigative dermatology 2015 Feb 135 (2): 542-50. Yin Jieyun, Liu Hongliang, Liu Zhensheng, Wang Li-E, Chen Wei V, Zhu Dakai, Amos Christopher I, Fang Shenying, Lee Jeffrey E, Wei Qing |
| Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing. PloS one 2015 10 (4): e0125571. Yang Xiaochen, Wu Jiong, Lu Jingsong, Liu Guangyu, Di Genhong, Chen Canming, Hou Yifeng, Sun Menghong, Yang Wentao, Xu Xiaojing, Zhao Ying, Hu Xin, Li Daqiang, Cao Zhigang, Zhou Xiaoyan, Huang Xiaoyan, Liu Zhebin, Chen Huan, Gu Yanzi, Chi Yayun, Yan Xia, Han Qixia, Shen Zhenzhou, Shao Zhimin, Hu Zh |
| Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer. Proceedings of the National Academy of Sciences of the United States of America 2014 Oct 111 (42): 15172-7. Kiiski Johanna I, Pelttari Liisa M, Khan Sofia, Freysteinsdottir Edda S, Reynisdottir Inga, Hart Steven N, Shimelis Hermela, Vilske Sara, Kallioniemi Anne, Schleutker Johanna, Leminen Arto, Bützow Ralf, Blomqvist Carl, Barkardottir Rosa B, Couch Fergus J, Aittomäki Kristiina, Nevanlinna He |
| RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families. Breast cancer research and treatment 2014 Aug 147 (1): 133-43. Blanco Ana, Gutiérrez-Enríquez Sara, Santamariña Marta, Montalban Gemma, Bonache Sandra, Balmaña Judith, Carracedo Angel, Diez Orland, Vega A |
| Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility alleles. Human mutation 2013 Dec 34 (12): 1615-8. Osorio Ana, Bogliolo Massimo, Fernández Victoria, Barroso Alicia, de la Hoya Miguel, Caldés Trinidad, Lasa Adriana, Ramón y Cajal Teresa, Santamariña Marta, Vega Ana, Quiles Francisco, Lázaro Conxi, Díez Orland, Fernández Daniel, González-Sarmiento Rogelio, Durán Mercedes, Piqueras José Fernández, Marín Maria, Pujol Roser, Surrallés Jordi, Benítez Javi |
| Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population. Molecular oncology 2013 Feb 7 (1): 85-100. Litim Nadhir, Labrie Yvan, Desjardins Sylvie, Ouellette Geneviève, Plourde Karine, Belleau Pascal, , Durocher Franci |
| Analysis of the novel fanconi anemia gene SLX4/FANCP in familial breast cancer cases. Human mutation 2013 Jan 34 (1): 70-3. Bakker Janine L, van Mil Saskia E, Crossan Gerry, Sabbaghian Nelly, De Leeneer Kim, Poppe Bruce, Adank Muriel, Gille Hans, Verheul Henk, Meijers-Heijboer Hanne, de Winter Johan P, Claes Kathleen, Tischkowitz Marc, Waisfisz Quint |
| BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. Cancer 2013 Jan 119 (2): 332-8. Pennington Kathryn P, Walsh Tom, Lee Ming, Pennil Christopher, Novetsky Akiva P, Agnew Kathy J, Thornton Anne, Garcia Rochelle, Mutch David, King Mary-Claire, Goodfellow Paul, Swisher Elizabeth |
| Assessment of SLX4 Mutations in Hereditary Breast Cancers. PloS one 2013 8 (6): e66961. Shah Sohela, Kim Yonghwan, Ostrovnaya Irina, Murali Rajmohan, Schrader Kasmintan A, Lach Francis P, Sarrel Kara, Rau-Murthy Rohini, Hansen Nichole, Zhang Liyng, Kirchhoff Tomas, Stadler Zsofia, Robson Mark, Vijai Joseph, Offit Kenneth, Smogorzewska Aga |
| Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families. European journal of human genetics : EJHG 2012 Dec . de Garibay GR, Díaz A, Gaviña B, Romero A, Garre P, Vega A, Blanco A, Tosar A, Díez O, Pérez-Segura P, Díaz-Rubio E, Caldés T, de la Hoya M |
| Novel germline PALB2 truncating mutations in African American breast cancer patients. Cancer 2012 Mar 118 (5): 1362-70. Zheng Yonglan, Zhang Jing, Niu Qun, Huo Dezheng, Olopade Olufunmilayo |
| Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families. BMC cancer 2012 12 (1): 84. Fernández-Rodríguez Juana, Quiles Francisco, Blanco Ignacio, Teulé Alex, Feliubadaló Lídia, Valle Jesús Del, Salinas Mónica, Izquierdo Angel, Darder Esther, Schindler Detlev, Capellá Gabriel, Brunet Joan, Lázaro Conxi, Pujana Miguel Ang |
| Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer. Human mutation 2011 Jun 32 (6): E2176-88. Hellebrand Heide, Sutter Christian, Honisch Ellen, Gross Eva, Wappenschmidt Barbara, Schem Christian, Deissler Helmut, Ditsch Nina, Gress Verena, Kiechle Marion, Bartram Claus R, Schmutzler Rita K, Niederacher Dieter, Arnold Norbert, Meindl Alfo |
| PALB2 analysis in BRCA2-like families. Breast cancer research and treatment 2011 Jun 127 (2): 357-62. Adank M A, van Mil S E, Gille J J P, Waisfisz Q, Meijers-Heijboer |
| Fanconi anemia gene mutations are not involved in sporadic Wilms tumor. Pediatric blood & cancer 2010 Oct 55 (4): 742-4. Adank Muriel A, Segers Heidi, van Mil Saskia E, van Helsdingen Yvette M, Ameziane Najim, van den Ouweland Ans M W, Wagner Anja, Meijers-Heijboer Hanne, Kool Marcel, de Kraker Jan, Waisfisz Quinten, van den Heuvel-Eibrink Marry |
| Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition. Carcinogenesis 2009 Nov 30 (11): 1898-902. García María J, Fernández Victoria, Osorio Ana, Barroso Alicia, Fernández Fernando, Urioste Miguel, Benítez Javi |
| The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features. Breast cancer research and treatment 2009 Jun . Barroso E, Pita G, Arias JI, Menendez P, Zamora P, Blanco M, Benitez J, Ribas G |
| Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families. Journal of human genetics 2008 53 (7): 579-91. Guénard Frédéric, Labrie Yvan, Ouellette Geneviève, Joly Beauparlant Charles, Simard Jacques, Durocher Francine, |
| PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nature genetics 2007 Feb 39 (2): 165-7. Rahman Nazneen, Seal Sheila, Thompson Deborah, Kelly Patrick, Renwick Anthony, Elliott Anna, Reid Sarah, Spanova Katarina, Barfoot Rita, Chagtai Tasnim, Jayatilake Hiran, McGuffog Lesley, Hanks Sandra, Evans D Gareth, Eccles Diana, , Easton Douglas F, Stratton Michael |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 12, 2022
- Content source: